6 December 2023
Nufarm ,a global crop protection and seed technology company, and IBI-Ag ,a pioneering biopest control company using antibodies as bioinsecticides, have announced a collaboration agreement which grants Nufarm exclusive rights to further develop, with an option to commercialize, several specific bioinsecticide candidates discovered by IBI-Ag.
IBI-Ag is a leading ag-biologicals company that develops single domain antibody insecticides to increase crop production with no harm to farmers, consumers and the environment. As an agricultural innovator, Nufarm is focused on innovative crop protection and seeds solutions, and the agreement grants Nufarm exclusive rights to further develop and an option to commercialize several specific bioinsecticide candidates discovered by IBI Ag.
This news appeared in AgReads.
We are thrilled about this exciting new collaboration with Nufarm, a renowned global leader in providing crop protection and seeds solutions. This partnership signifies a significant milestone for IBI-Ag, as it not only showcases our remarkable technological advancements but also underlines the strength of our product-market alignment and our comprehensive go-to-market strategy. By joining forces with Nufarm, we are confident that we will be able to amplify our impact in the agricultural sector and further contribute to the advancement of sustainable farming practices.
Arnon Heyman, CEO of IBI-Ag
Innovation and technology are the cornerstones of our future, and we focus on partnerships and collaborations to ensure we can access innovative solutions for our customers. This agreement gives us yet another avenue to provide better solutions to farmers now, and in the future.
Rico Christensen, Group Executive Portfolio, Nufarm.
See More News
Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device
Co-financing by the EIC Fund to ramp up women’s health solution to POP
Phytolon Secures Funding from Rich Products Ventures to Bring Natural Food Colors to Market
